Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional Outcome in Percutaneous Achilles Tendon Repair.
Bashir A, Parry MA, Bhat AA. Bashir A, et al. Among authors: parry ma. Indian J Orthop. 2023 Mar 2;57(6):917-922. doi: 10.1007/s43465-023-00852-3. eCollection 2023 Jun. Indian J Orthop. 2023. PMID: 37214370 Free PMC article.
Improving crop yield potential: Underlying biological processes and future prospects.
Burgess AJ, Masclaux-Daubresse C, Strittmatter G, Weber APM, Taylor SH, Harbinson J, Yin X, Long S, Paul MJ, Westhoff P, Loreto F, Ceriotti A, Saltenis VLR, Pribil M, Nacry P, Scharff LB, Jensen PE, Muller B, Cohan JP, Foulkes J, Rogowsky P, Debaeke P, Meyer C, Nelissen H, Inzé D, Klein Lankhorst R, Parry MAJ, Murchie EH, Baekelandt A. Burgess AJ, et al. Among authors: parry maj. Food Energy Secur. 2022 Dec 2;12(1):e435. doi: 10.1002/fes3.435. eCollection 2023 Jan. Food Energy Secur. 2022. PMID: 37035025 Free PMC article. Review.
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Parry MA, Grist E, Mendes L, Dutey-Magni P, Sachdeva A, Brawley C, Murphy L, Proudfoot J, Lall S, Liu Y, Friedrich S, Ismail M, Hoyle A, Ali A, Haran A, Wingate A, Zakka L, Wetterskog D, Amos CL, Atako NB, Wang V, Rush HL, Jones RJ, Leung H, Cross WR, Gillessen S, Parker CC, Chowdhury S; STAMPEDE collaborators; Lotan T, Marafioti T, Urbanucci A, Schaeffer EM, Spratt DE, Waugh D, Powles T, Berney DM, Sydes MR, Parmar MKB, Hamid AA, Feng FY, Sweeney CJ, Davicioni E, Clarke NW, James ND, Brown LC, Attard G. Parry MA, et al. Res Sq [Preprint]. 2023 Feb 8:rs.3.rs-2488586. doi: 10.21203/rs.3.rs-2488586/v1. Res Sq. 2023. PMID: 36798177 Free PMC article. Preprint.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
139 results